New report published by Global Info Research which offers insights on the global Biosimilar Monoclonal Antibodies market.
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-biosimilar-monoclonal-antibodies-market_p50659.html
Global Biosimilar Monoclonal Antibodies Market: Forecast by Type / Application / Region
The major players in global Biosimilar Monoclonal Antibodies market include: Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy’s, Celgen Biopharma, Cadila Healthcare, Hisun Pharma, Torrent Pharmaceuticals.
On the basis of product, the Biosimilar Monoclonal Antibodies market is primarily split into: Infliximab, Rituximab, Trastuzumab, Adalimumab, Other.
On the basis on the end users/applications covers: Oncology, Autoimmune Disease, Other.
In the last several years, global market of Biosimilar Monoclonal Antibodies developed rapidly, with an average growth rate of 32.6%. In 2017, global revenue of Biosimilar Monoclonal Antibodies is nearly 1500 M USD; the actual production is about 4.05 M Units.
Patent expirations on essential biological drugs is expected to create wider scope for potential opportunities for key players in the biosimilar monoclonal antibodies market in the near future.
However, lack of appropriate standards, stringent government regulations in developed countries, and high research and development costs for development of biosimilar monoclonal antibodies are some major factors restraining growth of the global biosimilar monoclonal antibodies market.
The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%, and the proportion is increasing trend from 2013 to 2018.
Biosimilar Monoclonal Antibodies is widely used for Oncology, Autoimmune Disease and Others. The most proportion of Biosimilar Monoclonal Antibodies is sales in Autoimmune Disease, and the consumption proportion is about 85.6% in 2017.
Europe is the largest consumption place, with a revenue market share nearly 51.4% in 2017. Following Europe, North America is the second largest consumption place with the revenue market share of 26.2%, China is also an important sales region for the Biosimilar Monoclonal Antibodies.
Market competition is intense. Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-biosimilar-monoclonal-antibodies-market_p50659.html
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
Europe Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
North America Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
Asia-Pacific Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
China Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
EMEA Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
Global Biosimilar Monoclonal Antibodies Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
